BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23411061)

  • 21. [Prognosis, staging and therapy of malignant pleural mesothelioma].
    Neumeister W; Gillissen A; Rasche K; Theile A; Müller KM; Schultze-Werninghaus G
    Med Klin (Munich); 2002 Aug; 97(8):459-71. PubMed ID: 12229245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of malignant pleural mesothelioma].
    Yusa T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):520-6. PubMed ID: 17431335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality approach in management of malignant pleural mesothelioma.
    Neragi-Miandoab S
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):14-9. PubMed ID: 16343925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse malignant pleural mesothelioma: Part I. An overview of diagnosis, staging, and treatment options.
    Brueggen C; Cordes ME
    Clin J Oncol Nurs; 2003; 7(4):431-7. PubMed ID: 12929277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A catalogue of treatment and technologies for malignant pleural mesothelioma.
    Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
    Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience in treating patients with malignant pleural mesothelioma].
    Uramoto H; Shimokawa H; Baba T; Shigematsu Y; Nagata Y; Ono K; Takenoyama M; Hanagiri T
    J UOEH; 2010 Sep; 32(3):257-64. PubMed ID: 20857819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality management of malignant pleural mesothelioma.
    Sugarbaker DJ; Norberto JJ
    Chest; 1998 Jan; 113(1 Suppl):61S-65S. PubMed ID: 9438692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of malignant pleural mesothelioma: have we made any progress?
    Hiddinga BI; Surmont VF; Van Meerbeeck JP
    Panminerva Med; 2013 Jun; 55(2):157-73. PubMed ID: 23676957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.
    Song KJ; Flores RM; Wolf AS
    Thorac Surg Clin; 2020 Nov; 30(4):481-487. PubMed ID: 33012435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innovative therapies for malignant pleural mesothelioma.
    Roberts JR
    Chest; 1997 Oct; 112(4 Suppl):269S-271S. PubMed ID: 9337302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malign pleural mesothelioma - so far an undefeated tumor].
    Kolek V
    Vnitr Lek; 2018; 63(11):884-888. PubMed ID: 29303291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Concepts in the Treatment of Malignant Pleural Mesothelioma.
    Wald O; Sugarbaker DJ
    Annu Rev Med; 2018 Jan; 69():365-377. PubMed ID: 29029582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma.
    Du KL; Both S; Friedberg JS; Rengan R; Hahn SM; Cengel KA
    Cancer Biol Ther; 2010 Sep; 10(5):425-9. PubMed ID: 20699634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the management of malignant mesothelioma.
    Khalil MY; Mapa M; Shin HJ; Shin DM
    Curr Oncol Rep; 2003 Jul; 5(4):334-41. PubMed ID: 12781077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodality treatment of pleural mesothelioma.
    Shersher DD; Liptay MJ
    Surg Oncol Clin N Am; 2013 Apr; 22(2):345-55. PubMed ID: 23453339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.